Skip to main content
ELI LILLY & Co logo

ELI LILLY & Co — Investor Relations & Filings

Ticker · LLY ISIN · US5324571083 LEI · FRDRIPF3EKNDJ2CQJL29 US Manufacturing
Open in API
Filings indexed 3,870 across all filing types
Latest filing 2019-03-22 Proxy Solicitation & In…
Country US United States of America
Listing US LLY

About ELI LILLY & Co

https://www.lilly.com/

Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or related materials filed with the SEC. It includes information about the company's board priorities, management proposals related to governance changes (eliminating classified board structure and supermajority voting), and references to shareholder voting matters. The document is titled 'Definitive Additional Materials' related to a proxy statement, which aligns with Proxy Solicitation & Information Statement filings. The content focuses on providing information to shareholders to solicit votes for upcoming meetings rather than being the actual annual report, earnings release, or other financial filings. The document length is 4085 characters, which is consistent with a proxy statement or related materials rather than a full annual report or detailed financial report. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2019-03-22 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is identified as a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as "Definitive Additional Materials" related to a proxy statement for Eli Lilly and Company. Proxy statements and related materials are used to solicit shareholder votes and provide information for meetings. This matches the description of Proxy Solicitation & Information Statement filings (PSI). The document length is 2342 characters, which is consistent with a proxy statement or related materials rather than a full annual report or other financial report. Therefore, the correct classification is PSI.
2019-03-22 English
DEF 14A
Proxy Solicitation & Information Statement
2019-03-22 English
ELI LILLY AND COMPANY CALLS STOCKHOLDERS MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, as indicated by the header and the title 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934'. It includes detailed information about the 2019 Annual Meeting of Shareholders, including items of business such as election of directors, advisory vote on executive compensation, ratification of auditors, and amendments to articles of incorporation. The content covers governance, board nominations, compensation discussion, and shareholder proposals. This matches the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is PSI with high confidence.
2019-03-22 English
FORM 4
Director's Dealing
2019-03-20 English
FORM 4
Director's Dealing
2019-03-20 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.